About

Blue Shift publishes Ibogaine Hockey as an independent information resource for athletes, families, and communities navigating questions where ibogaine intersects with concussion, recovery, and life after sport.

We do not offer medical care or legal counsel; our role is to gather, clarify, and point readers toward primary evidence and context.

Explore our homepage See how our editorial services are organized
Close-up detail view related to Ibogaine for Hockey showing textured surface and subtle color refractions

Our editorial approach

Ibogaine Hockey focuses on clear, evidence-aware synthesis rather than advocacy. We explain how questions are framed, point to original registries and literature, and highlight gaps and uncertainties so readers can weigh options with their healthcare teams.

We try to ground editorial claims in primary sources such as clinical registries and established repositories; for methods guidance we consult broadly accepted standards (for example, how clinical registries are described on Wikipedia's registry overview at Registry (clinical research)), and when legal or policy context is relevant we refer readers to authoritative government pages like the U.S. National Library of Medicine at nlm.nih.gov for further context.

How we source material

Our editorial process favors primary literature, clinical registries, and official guidance. Content is curated from open registries and peer-reviewed sources and cross-checked against established summaries at academic institutions or regulatory bodies when available.

We do not provide medical advice. Our content is informational and intended to support informed conversations with qualified professionals.

Editorial principles

  • Independence: we do not provide or broker treatments and we avoid commercial influence.
  • Plain language: technical ideas are translated without losing rigor.
  • Evidence awareness: we cite registries and primary sources, and we highlight uncertainty.
  • Harm reduction: practical safety information is prioritized when topics affect health.
  • Human dignity: coverage centers people, not promotional claims.

To understand how our editorial work relates to services that some readers may seek, our services page describes the informational products we publish and the types of background research we perform.

Independent by design

Blue Shift publishes Ibogaine Hockey as an independent information resource. We are not a clinic, medical provider, or licensed treatment center, and our content does not replace guidance from qualified health or legal professionals.

Readers interested in treatment logistics sometimes ask about cost or availability; for an external overview of treatment pricing models we link to an industry resource at ibogaine treatment costs so readers can see how pricing is discussed outside editorial coverage.

We also anchor methodological claims with established references; for instance, synthesis methods align with transparent reporting norms referenced in academic overviews such as systematic review summaries, and registry standards are described by major institutions including the National Library of Medicine.

Questions about our coverage?

For editorial inquiries, or to report an error in our content, please use the contact page linked in our navigation; our contact listing explains how to reach Ibogaine Hockey without implying clinical services.

Frequently asked editorial questions

How do you pick sources?

We prioritize primary sources and registries, and when we summarize secondary literature we prefer peer-reviewed outlets and institutional guidance. Where appropriate we link readers to authoritative overviews such as the U.S. National Library of Medicine to verify clinical context.

Are you affiliated with treatment providers?

No. Ibogaine Hockey is independent; we do not endorse or refer to specific clinics. Readers seeking services should consult qualified professionals. Our editorial disclosure in the footer reiterates this independence and non-clinical status.

Can I suggest a source?

You may propose sources via the contact page. When readers suggest registry entries or published papers we evaluate them against our sourcing criteria and explain any decisions openly in the editorial record.